Skip to main content
Veterinary Medicines

Cepravin Dry Cow 250 mg Intramammary suspension

Not authorised
  • Cefalonium dihydrate

Product identification

Medicine name:
Cepravin Dry Cow 250 mg, intramammaarsuspensioon
Cepravin Dry Cow 250 mg Intramammary suspension
Active substance:
  • Cefalonium dihydrate
Target species:
  • Cattle (dairy cow at drying-off)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cefalonium dihydrate
    269.60
    milligram(s)
    /
    3.00
    gram(s)
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (dairy cow at drying-off)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51DB90
Authorisation status:
  • Surrendered
Authorised in:
  • Estonia
Package description:
  • (ID2) 432 gram(s): Behältnis with 144 Syringe (PolyEthylene) each with 3 gram(s), closed with Lid (PolyEthylene)
  • (ID1) 60 gram(s): Box (Cardboard) with 20 Syringe (PolyEthylene) each with 3 gram(s), closed with Lid (PolyEthylene)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Trirx Segre
  • Intervet International GmbH
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1729
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0184/001

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 4/04/2023

Combined File of all Documents

English (PDF)
Published on: 30/01/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."